Exercise in Patients With End Stage Kidney Disease
A Simple Exercise Program for Patients With End Stage Kidney Disease to Improve Strength and Quality of Life: A Feasibility Study
1 other identifier
interventional
90
1 country
1
Brief Summary
This study will be conducted over a 3 year time period. This is a trial of an exercise intervention vs. standard of care in patients receiving chronic dialysis. The specific aims will be to determine feasibility of patient recruitment, adherence to the exercise program, and efficacy of the intervention on patient important outcomes. The exercise intervention will be delivered to randomized participants for 12 months, and consist of the prescribed use of Nordic Walking poles, online resources for exercise in the home, regular use of a pedometer to monitor progress, and regular verbal encouragement to exercise (monthly) by dialysis unit staff. Both groups will receive the same standard of care co-interventions including individualized dialysis prescriptions and health-care interactions according to practices at their centre.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2018
CompletedFirst Posted
Study publicly available on registry
December 26, 2018
CompletedStudy Start
First participant enrolled
April 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2025
CompletedJune 26, 2024
June 1, 2024
5.8 years
October 1, 2018
June 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Recruitment Feasibility
The investigators will assess at each centre the number of participants receiving dialysis, approached for participation, eligible to participate and any reasons for non-participation.
30 months
Adherence
Two-week step counts with a pedometer will be monitored monthly in the treatment group, and at baseline, 6 and 12 months in the control group.
12 months
Secondary Outcomes (7)
Hand Grip Strength
12 months
Quality of Life using Vitality Subscale
12 months
Sleep Quality
12 months
Hospitalizations
12 months
Hospital Length of Stay
12 months
- +2 more secondary outcomes
Study Arms (2)
Exercise Intervention
EXPERIMENTALParticipants in this arm will receive standard of care along with the exercise prescription intervention
Standard of Care
NO INTERVENTIONThis group will receive standard of care treatment including regular verbal encouragement to exercise (monthly) by dialysis unit staff.
Interventions
Participants in the intervention group will be given an exercise prescription to increase their baseline steps by 1200 and 2000 steps per day at least 3 days a week over the first 3 months. If tolerated and accepted, the participants will increase their step counts by an additional 600 to 1000 steps per day at least 3 days a week for the next 3 months.This will be followed by a 6-month maintenance phase. The research coordinator will instruct the participants on the proper use of the Nordic walking poles which can be used to help participants achieve their prescribed number of steps. All participants will be encouraged to wear the pedometer throughout the trial in order to follow the step-count prescription and monitor adherence.
Eligibility Criteria
You may qualify if:
- All ambulatory adult patients with end stage kidney disease
- Treatment with peritoneal dialysis or hemodialysis for greater than six months
- Able to understand English or French
- Abuse to use Nordic Walking poles
- Able and willing to provide informed consent
You may not qualify if:
- Any absolute contraindication to exercise \[unstable angina, uncontrolled hypertension (systolic or diastolic blood pressure greater than 180 mmHg (millimeters of mercury) or greater than 110 mmHg, respectively), deemed not suitable for exercise by the treating physician\]
- Baseline step count greater than 8000 steps a day
- Planned living donor kidney transplant
- Potential for recovery of renal function
- Patients who feel unsafe using Nordic walking poles in place of their mobility aid
- Participation in another interventional trial that may affect the results of this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ottawa Hospital
Ottawa, Ontario, K1H 1A2, Canada
Related Publications (1)
Suri RS, Moist L, Lok C, Clase CM, Harris J, Reid RD, Ramsay T, Zimmerman D. A Simple Exercise Program for Patients With End-Stage Kidney Disease to Improve Strength and Quality of Life: Clinical Research Protocol. Can J Kidney Health Dis. 2023 Oct 26;10:20543581231205160. doi: 10.1177/20543581231205160. eCollection 2023.
PMID: 37901358DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah Zimmerman, MD, MSc
Ottawa Hospital Research Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2018
First Posted
December 26, 2018
Study Start
April 15, 2019
Primary Completion
January 31, 2025
Study Completion
September 15, 2025
Last Updated
June 26, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- One year after publication up to 3 years post publication
- Access Criteria
- researchers with methodologically sound proposals approved by the principal investigator
The study protocol, manual of operations and consent form will be made available by contacting the corresponding author. De-identified patient data will be available from 12 months to 3 years after manuscript publication to researchers with methodologically sound proposals approved by the principal investigator.